Anika Therapeutics, Inc.ANIKNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-2.33M
↓ 117% below average
Average (9y)
$13.80M
Historical baseline
Range
High:$34.18M
Low:$-7.21M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-2.33M | +67.7% |
| 2023 | $-7.21M | -134.5% |
| 2022 | $-3.08M | -194.6% |
| 2021 | $3.25M | -71.5% |
| 2020 | $11.44M | -66.5% |
| 2019 | $34.18M | +12.9% |
| 2018 | $30.26M | -4.9% |
| 2017 | $31.83M | +225.2% |
| 2016 | $9.79M | -67.2% |
| 2015 | $29.84M | - |